DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 018676
NDA 018676 describes HEPATAMINE 8%, which is a drug marketed by B Braun and is included in one NDA. It is available from one supplier. Additional details are available on the HEPATAMINE 8% profile page.
The generic ingredient in HEPATAMINE 8% is amino acids. There are three hundred and forty-eight drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the amino acids profile page.
The generic ingredient in HEPATAMINE 8% is amino acids. There are three hundred and forty-eight drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the amino acids profile page.
Summary for 018676
| Tradename: | HEPATAMINE 8% |
| Applicant: | B Braun |
| Ingredient: | amino acids |
| Patents: | 0 |
| Formulation / Manufacturing: | see details |
Suppliers and Packaging for NDA: 018676
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| HEPATAMINE 8% | amino acids | INJECTABLE;INJECTION | 018676 | NDA | B. Braun Medical Inc. | 0264-9371 | 0264-9371-55 | 6 CARTON in 1 CASE (0264-9371-55) > 1 CONTAINER in 1 CARTON > 500 mL in 1 CONTAINER |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 8% (8GM/100ML) | ||||
| Approval Date: | Aug 3, 1982 | TE: | RLD: | No | |||||
Expired US Patents for NDA 018676
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| B Braun | HEPATAMINE 8% | amino acids | INJECTABLE;INJECTION | 018676-001 | Aug 3, 1982 | ➤ Try a Free Trial | ➤ Try a Free Trial |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
Complete Access Available with Subscription
